1,10-phenanthroline has been researched along with Granulocytic Leukemia in 2 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, B | 1 |
| Wu, KF | 1 |
| Cao, ZY | 1 |
| Rao, Q | 1 |
| Ma, XT | 1 |
| Zheng, GG | 1 |
| Li, G | 1 |
| Sestili, P | 1 |
| Guidarelli, A | 1 |
| Dachà , M | 1 |
| Cantoni, O | 1 |
2 other studies available for 1,10-phenanthroline and Granulocytic Leukemia
| Article | Year |
|---|---|
IL-18 increases invasiveness of HL-60 myeloid leukemia cells: up-regulation of matrix metalloproteinases-9 (MMP-9) expression.
Topics: Antibodies, Monoclonal; Cell Movement; Extracellular Matrix; Gene Expression Regulation, Enzymologic | 2004 |
Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism.
Topics: Antioxidants; Butylated Hydroxytoluene; Cell Death; Chromans; Copper; DNA Damage; Dose-Response Rela | 1998 |